Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Meclofenamic acid
Cat. No.:
OB0425LY-384
Appearance:
Solid
Purity:
98.08%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Meclofenamic acid is a highly selective FTO enzyme inhibitor that inhibits hKv1 and hKv1.
Synonyms:
Meclofenamate; 644-62-2; 2-[(2,6-Dichloro-3-methylphenyl)amino]benzoic acid; N-(2,6-Dichloro-m-tolyl)anthranilic acid; 2-(2,6-Dichloro-3-methylanilino)benzoic acid
CAS No.:
644-62-2
Compound CID:
4037
Formula:
C14H11Cl2NO2
Formula Weight:
296.15
Specification
Target:
Gap junction protein; Endogenous metabolite; Fat mass and obesity-associated protein (FTO); Potassium channel
Pathway:
Cytoskeleton; Metabolic enzyme/Protease; Membrane transporter/Ion channel
Solubility:
DMSO, Methanol
Storage:
Storage at -20°C.
Applications:
Meclofenamic acid can be used as an anticancer agent through the inhibition of certain signaling pathways.
